Although both blepharitis and styes affect the eyelids, the two conditions have different symptoms, causes, and treatment options. To help prevent developing a stye or blepharitis, a person can ...

But one ingredient that’s gone viral on TikTok is worth paying attention to: hypochlorous acid. It’s a soothing, potent ...

If you think you might have blepharitis, you can ask your healthcare provider for a referral to an eye care specialist. Through a comprehensive eye exam, they can identify the cause of your symptoms ...

Generated $48.1 million in XDEMVY® net product sales driven by more than 41,400 bottles delivered to patients in the third quarterStrengthened ...

Dry skin is a common factor behind the occurrence of dandruff on eyelashes and eyebrows. Therefore, petroleum jelly is an effective treatment for blepharitis as it moisturizes the skin, preventing ...

As the first treatment cleared by the FDA for Demodex blepharitis, an eye disease estimated to affect 25 million people in the U.S. alone, Tarsus Pharmaceuticals’ Xdemvy is pitting its might ...

Most styes don’t require treatment and go away on their own ... This is known as blepharitis. Blepharitis can develop when you don’t keep your eyelids clean and free of crusts.

Humana CMO brings more than two decades of experience driving innovative, value-based initiatives designed to improve patient outcomesIRVINE, ...

Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as ...

This clear documentation will guide the clinician in comparing previous to subsequent TVDs in the same patient and may aid in the assessment of the efficacy of the treatment modalities administered.

“For years, millions of patients with Demodex blepharitis have struggled with limited, suboptimal treatment options and the frustration of not being able to address the root cause of their ...

Detailed price information for Tarsus Pharmaceuticals Inc (TARS-Q) from The Globe and Mail including charting and trades.